Viewing Study NCT06834451


Ignite Creation Date: 2025-12-24 @ 11:43 PM
Ignite Modification Date: 2025-12-27 @ 10:22 PM
Study NCT ID: NCT06834451
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-06-19
First Post: 2025-01-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Bioequivalence Study of Revolade® Eltrombopag 50 mg
Sponsor: Centro de Atencion e Investigacion Medica
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module